AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Nephros Inc.
XNAS · usd
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG001SL04M7
3.53▲ 0.01 (0.28%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
3.52
Day's Range
3.50 – 3.77
52-Week Range
2.60 – 6.42
Volume
45.5K
Avg Volume
34.7K
Share Statistics
Shares Outstanding
Employees
36
Exchange
XNAS
Listed
2004-09-21
Share count as of August 7, 2026

Nephros Inc. (NEPH) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Nephros Inc. (NEPH)
What is Nephros Inc.'s Market Cap?
Nephros Inc.'s Market Cap is $38.3M, based on as-reported figures from SEC (XBRL) filings.
What is Nephros Inc.'s Enterprise Value?
Nephros Inc.'s Enterprise Value is $33.7M, based on as-reported figures from SEC (XBRL) filings.
What is Nephros Inc.'s Trailing P/E?
Nephros Inc.'s Trailing P/E is 22.1×, based on as-reported figures from SEC (XBRL) filings.
What is Nephros Inc.'s Price / Sales?
Nephros Inc.'s Price / Sales is 1.9×, based on as-reported figures from SEC (XBRL) filings.
What is Nephros Inc.'s EV / Revenue?
Nephros Inc.'s EV / Revenue is 1.6×, based on as-reported figures from SEC (XBRL) filings.
What is Nephros Inc.'s EV / EBITDA?
Nephros Inc.'s EV / EBITDA is 19.1×, based on as-reported figures from SEC (XBRL) filings.
What is Nephros Inc.'s Revenue (TTM)?
Nephros Inc.'s Revenue (TTM) is $20.7M, based on as-reported figures from SEC (XBRL) filings.
What is Nephros Inc.'s Net Income (TTM)?
Nephros Inc.'s Net Income (TTM) is $1.7M, based on as-reported figures from SEC (XBRL) filings.
What is Nephros Inc.'s EBITDA?
Nephros Inc.'s EBITDA is $1.8M, based on as-reported figures from SEC (XBRL) filings.
What is Nephros Inc.'s Diluted EPS (TTM)?
Nephros Inc.'s Diluted EPS (TTM) is 0.16, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · NEPHAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Net revenue:
Revenue
YoY growth+36.2%+6.9%+22.2%+35.4%
Cost of Revenue
Gross margin
% of revenue66.9%57.4%58.4%61.2%
Operating expenses:
Selling, General and Administrative Expense
Research and Development Expense
Depreciation Expense
Total operating expenses
% of revenue46.8%55.6%58.0%54.6%
Operating income
% of revenue20.2%1.9%0.4%6.6%
Other (expense) income:
Interest expense—
Interest Income
Non-Operating Income (Expense)
Total other income (expense):
Income before income taxes—
Income tax expense—
Net income
% of revenue19.9%2.7%1.3%7.1%
Earnings Per Share (Basic)
Earnings Per Share (Diluted)